Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.
REGISTER NOW & SAVE

Barry-Wehmiller acquires Mateer Burt

Barry-Wehmiller gains filling and labeling manufacturing capabilities with Mateer Burt acquisition.

Robert Chapman, chairman/CEO of Barry-Wehmiller Companies, Inc., St. Louis, MO, announced the May 28 acquisition of the majority of the assets and business of Mateer Burt, a leading domestic manufacturer of auger filling and labeling equipment serving the pharmaceutical, food, beverage, and personal care markets.

“Filling and labeling technology is a focus for market leadership, and this acquisition will accelerate the achievement of our strategic goals,” stated Timothy J. Sullivan, Barry-Wehmiller group executive.

Mateer Burt’s auger fillers will be integrated with Barry-Wehmiller’s filler product lines, enhancing its dry filling capabilities and significantly broadening its customer base. Furthermore, Mateer Burt’s pressure-sensitive labeling products will enhance Barry-Wehmiller’s current labeling capabilities.

This purchase represents the 21st acquisition in 14 years for Barry-Wehmiller. For more information see the company Web site at www.barry-wehmillerco.com.

Annual Outlook Report: Sustainability
The road ahead for CPGs in 2025 and beyond—<i>Packaging World</i> editors review key findings from a survey of 88 brand owners, CPG, and FMCG readers.
Download Now
Annual Outlook Report: Sustainability
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report